Regencell Bioscience Holdings Ltd reported an At-the-Market Offering of Ordinary Shares on March 30, 2026. This event is significant for investors as it reflects a capital raise.
AI Assistant
REGENCELL BIOSCIENCE HOLDINGS LTD
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.